Skip to content
Use caution Drug recall · FDA · Published March 2, 2023

Endo Recalls Calcitonin Salmon Nasal Spray Due to Impurity Issues

Endo Pharmaceuticals recalls specific lots of Calcitonin Salmon Nasal Spray due to failed impurity specifications and subpotent drug risks.

🇺🇸 FDA recall #D-0475-2023DrugEndo Pharmaceuticals ›
Take action

Contact the company

Recalling firmEndo Pharmaceuticals, Inc.1400 Atwater Dr · Malvern, PA 19355-8701
✎ GovInfoNow plain-language explainer

Endo Pharmaceuticals, Inc. is recalling Calcitonin Salmon Nasal Spray, USP because certain batches contain high levels of known and unknown impurities and may be subpotent (weaker than labeled). The affected lots were manufactured by Par Pharmaceutical and distributed nationwide in the USA and Puerto Rico. Consumers should check their bottle's lot number against the recall list to determine if it is affected. Read more at govinfonow.com/recall/33829-endo-recalls-calcitonin-salmon-nasal-spray-due-to-impurity-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/33829-endo-recalls-calcitonin-salmon-nasal-spray-due-to-impurity-issues · Updated October 10, 2026 · FDA enforcement record: FDA #D-0475-2023

Cite this page

“Endo Recalls Calcitonin Salmon Nasal Spray Due to Impurity Issues.” GovInfoNow, updated October 10, 2026. https://govinfonow.com/recall/33829-endo-recalls-calcitonin-salmon-nasal-spray-due-to-impurity-issues. Based on FDA recall #D-0475-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0475-2023%22&limit=1).

The FDA announced on March 2, 2023, that Endo Pharmaceuticals, Inc. is recalling Calcitonin Salmon Nasal Spray due to failed impurity specifications and subpotent drug issues. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Endo Pharmaceuticals
  • Product: Calcitonin Salmon Nasal Spray, USP
  • Strength: 2200 International Units per mL corresponding to 200 International Units/spray
  • Size: 3.7 mL bottle
  • NDC: 49884-161-11
  • Lot codes and expiration dates: 34770301 (Mar-23), 34770401 (May-23), 12981201 (Nov-23), 13037201 (Dec-23), 13037301 and 13647801 (Feb-24), 13722101 (Mar-24), 13980101 and 13980001 (Apr-24), 14461701 and 14461801 (Jul-24), 14706201 (Aug-24), 14935601 (Oct-24), 5500131A and 5500132A (Mar-25)
  • Quantity: 372,938 bottles
  • Distribution: Nationwide in the USA and Puerto Rico

The hazard

According to the FDA, the recalled Calcitonin Salmon Nasal Spray has high out-of-specification results for known and unknown impurities as well as low out-of-specification results for assay. This constitutes a failed impurity/degradation specification and subpotent drug hazard.

Context

GovInfoNow's records show Endo Pharmaceuticals, Inc. has four other recalls on record since May 7, 2012. Other recent recalls of similar products include Endo Clonazepam Tablets Recalled Due to Labeling Error (July 10, 2024), Endo Robaxin 750mg Tablets: Incorrect Dosage Label Recall (Sept. 17, 2018), and Endo Edex 10mcg injection recall (Feb. 22, 2017). Other recent recalls of similar products include Sun Pharmaceutical Fluocinolone Acetonide Solution Recall (Dec. 30, 2025) and SUN PHARMA Ciclopirox Shampoo 1% Recall (Dec. 9, 2025).

How to tell if you have this one

Look for Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL in a 3.7 mL bottle. Check the NDC number (49884-161-11) and the lot number on the label. Affected lots include: 34770301, 34770401, 12981201, 13037201, 13037301, 13647801, 13722101, 13980101, 13980001, 14461701, 14461801, 14706201, 14935601, 5500131A, and 5500132A.

  • Brand
    Endo Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Lot Number

    Compare the lot number on your Calcitonin Salmon Nasal Spray bottle against the list of recalled lots provided in the recall record.

  2. Contact Your Pharmacist or Doctor

    If you have a recalled lot, speak with your healthcare provider or pharmacist to discuss alternative treatment options or replacement.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide in the USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 20 months after the firm started it.

1. Firm started the recall: Mar 2, 202312. FDA classified it Class II: Mar 24, 202323. Published in FDA’s Enforcement Report: Apr 5, 202334. FDA terminated the recall: Nov 8, 2024420232024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What are the expiration dates for the recalled lots?

Expiration dates vary by lot: Mar-23, May-23, Nov-23, Dec-23, Feb-24, Mar-24, Apr-24, Jul-24, Aug-24, Oct-24, and Mar-25.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0475-2023 (March 2, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0475-2023 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA